s per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...

Wockhardt is recalling 93,393 bottles of Captopril tablets, used for treatment of high blood pressure and kidney problems caused by diabete...

Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued.

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.

Two drugs - WCK 771 and WCK 2349 - have received QIDP status, which allows fast-track review of the drug application by the USFDA.

Wockhardt is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets following failure of a di...

Drug firm Wockhardt today reported a consolidated net loss of Rs 191.64 crore for the quarter ended March 31, 2012 burdened by exceptional ...

Shares of Wockhardt gained over 4% after the pharmaceutical major received final approval from the US FDA for marketing nasal spray of Flut...

Drug firm Wockhardt today reported a consolidated net profit of Rs 127.58 crore for the second quarter ended September 30, 2011 on improved...

The Mumbai-based company had posted a net loss of Rs 189.87 crore in the corresponding quarter of the previous fiscal.

Pharmaceutical firm Wockhardt on Tuesday said it will shortly launch Azithromycin tablets, which are used for treating different kinds of i...

Pharmaceutical major Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a liquid generic and specialty dermatology company in the US ...

Wockhardt will now be able to market the full range of its potent antibiotic injection, Ceftriaxone, in America as it has received the US F...

Wockhardt Ltd today said it has got US FDA approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate a...

Wockhardt Ltd on Thursday said it has received approval from USFDA for marketing antibiotic Cefotaxime sodium injection in the US market.

Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.